Clearline Capital’s eHealth EHTH Stock Holding History

Clearline Capital’s Portfolio EHTH Stock Details EHTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,953	Closed	-$840K	–	140
2021 Q4	$840K	Hold	32,953	–	–	0.09%	98
2021 Q3	$1.33M	Buy	+32,953	New	+$1.54M	0.13%	94

Other funds holding EHTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HEC

Hudson Executive Capital New York $50.9M AUM 22.11% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Clearline Capital's EHTH Position: Q1 2022 in Review

Clearline Capital sold out of eHealth (EHTH) in Q1 2022, closing a stake of 32,953 shares — an estimated $840K sold.

Clearline Capital first reported a position in EHTH in Q3 2021 and held it in 2 quarters. The position peaked at $1.33M in Q3 2021. 160 funds tracked by Wall St. Rank hold EHTH as of Q1 2022.

Clearline Capital reported no remaining eHealth position as of Q1 2022 after selling out during the quarter.
Clearline Capital sold 32,953 eHealth shares in Q1 2022, an estimated $840K.
Clearline Capital first reported a position in eHealth in Q3 2021 and held it in 2 quarters.
Clearline Capital's eHealth position peaked at $1.33M in Q3 2021.
160 funds tracked by Wall St. Rank held eHealth as of Q1 2022.

Based on Clearline Capital's 13F filing for Q1 2022, filed 16 May 2022.